Drugs / SPARC1028
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01305512 | May 2012 → Jun 2016 | — | Sun Pharma Advanced Research Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC1028 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01305512 ↗ |
| Route | Intravenous | “30-minute intravenous infusion” NCT01305512 ↗ |